Leading healthcare organizations and research institutions in India have leveraged NVIDIA NIM microservices and artificial intelligence to drive breakthrough medical research and build powerful medical applications.
NVIDIA NIM microservices, including the new Nemotron-4-Mini-Hindi 4B microservice, enable new AI applications and large natural language models to be built in Hindi.
The new AI model has the potential to dramatically improve healthcare accessibility by investing in AI models designed within the country through initiatives like the IndiaAI Mission.
The IIT Madras Brain Centre is advancing neuroscience research using AI to analyze vast petabyte-sized datasets, accelerating research that could lead to life-saving discoveries.
IIIT-Delhi researchers predict that AI-guided antimicrobial stewardship will be a key component of preventing the tens of millions of deaths that could be caused by antimicrobial resistance between 2025 and 2050.
Bionic, developed by 5C Network, detected pathologies in scans, such as lung lesions in X-rays or brain masses in MRIs, and provided actionable insights to support clinicians in decision-making.
Innoplexus, a member of the Nvidia Inception program, has built an AI-powered life sciences platform for drug discovery powered by NVIDIA NIM, including the AlphaFold2 NIM microservice.
Using NVIDIA NIM microservices, Innoplexus generates synthetic patient data to boost its AI models and performs virtual screenings of 5.8 million small molecules in less than eight hours — 10x faster than without NIM.
NVIDIA NIM microservices are available as part of the NVIDIA AI Enterprise software platform that enables the creation of smarter and more efficient healthcare facilities.
Global system integrators, including Infosys, TCS, Tech Mahindra, and Wipro, are collaborating with NVIDIA to help life sciences and healthcare companies leverage generative AI advancements.